Takayoshi Ito
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Takayoshi Ito has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Asep Sudarman
Department of Animal Nutrition and Feed Technology, Faculty of Animal Science, IPB University, Jl. Raya Dramaga Kampus IPB Dramaga Bogor, Bogor, 16680, Indonesia
2 shared publications - Akira Kikuchi
Center for Infectious Disease Education and Research (CiDER), The University of Osaka, 1-10 Yamadaoka, Suita, Osaka, 565-0871, Japan.
1 shared publication - Atsushi Ono
Department of Gastroenterology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8553, Japan
1 shared publication - Bo Li
Laboratory of Immune Regulation, Department of Microbiology and Immunology, Graduate School of Medicine, University of Osaka, Suita, Osaka 565-0871, Japan
1 shared publication - Daisuke Motooka
Research Institute for Microbial Diseases, Osaka University, Osaka, Japan
1 shared publication - Daisuke Okuzaki
Laboratory for Human Immunology (Single Cell Genomics), WPI Immunology Frontier Research Center, The University of Osaka, Suita 565-0871, Japan
1 shared publication
Latest Publications
- 18 July 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 10 (109) , eadm6843
OTUD3 prevents ulcerative colitis by inhibiting microbiota-mediated STING activation
Ulcerative colitis (UC) develops through a complicated interaction between the host and microbiota. Intestinal fibroblasts are believed to play crucial roles in the pathogenesis of UC, but the influence of the host-microbiota interaction on the pathophysiology of intestinal fibroblasts remains poorly understood. Here, we demonstrate that OTU deubiquitinase 3 (OTUD3) suppresses pathologic activation of fibroblasts exposed to microbial cyclic GMP-AMP (3′3’-cGAMP) in the colon by deubiquitinating stimulator of interferon genes (STING). Mice harboring a UC risk missense variant in the Otud3 gene showed pathological features of UC in the colon after transplantation of a fecal microbiota with the potential to produce excessive cGAMP from patients with UC. Collectively, these results highlight a mechanism of the interaction between OTUD3 in host fibroblasts and STING-activating microbiota in UC development.
- 18 July 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 10 (109) , eadm6843
OTUD3 prevents ulcerative colitis by inhibiting microbiota-mediated STING activation
Ulcerative colitis (UC) develops through a complicated interaction between the host and microbiota. Intestinal fibroblasts are believed to play crucial roles in the pathogenesis of UC, but the influence of the host-microbiota interaction on the pathophysiology of intestinal fibroblasts remains poorly understood. Here, we demonstrate that OTU deubiquitinase 3 (OTUD3) suppresses pathologic activation of fibroblasts exposed to microbial cyclic GMP-AMP (3′3’-cGAMP) in the colon by deubiquitinating stimulator of interferon genes (STING). Mice harboring a UC risk missense variant in the Otud3 gene showed pathological features of UC in the colon after transplantation of a fecal microbiota with the potential to produce excessive cGAMP from patients with UC. Collectively, these results highlight a mechanism of the interaction between OTUD3 in host fibroblasts and STING-activating microbiota in UC development.
- Open Access
- 1 November 2000
- Published by Asian Australasian Association of Animal Production Societies in Asian-Australasian Journal of Animal Sciences
- Vol. 13 (11) , 1523-1528
Effects of Dietary Protein Sources and Levels on Heat Production and Thermoregulatory Responses of Sheep Exposed to a High Ambient Temperature
- 1 November 2000
- Published by Asian Australasian Association of Animal Production Societies in Asian-Australasian Journal of Animal Sciences
- Vol. 13 (11) , 1523-1528
Open AccessEffects of Dietary Protein Sources and Levels on Heat Production and Thermoregulatory Responses of Sheep Exposed to a High Ambient Temperature
- Open Access
- 1 May 2000
- Published by Asian Australasian Association of Animal Production Societies in Asian-Australasian Journal of Animal Sciences
- Vol. 13 (5) , 625-629
Heat Production and Thermoregulatory Responses of Sheep Fed Different Roughage Proportion Diets and Intake Levels When Exposed to a High Ambient Temperature
- 1 May 2000
- Published by Asian Australasian Association of Animal Production Societies in Asian-Australasian Journal of Animal Sciences
- Vol. 13 (5) , 625-629
Open AccessHeat Production and Thermoregulatory Responses of Sheep Fed Different Roughage Proportion Diets and Intake Levels When Exposed to a High Ambient Temperature
- Open Access
- 1 June 1997
- Published by Asian Australasian Association of Animal Production Societies in Asian-Australasian Journal of Animal Sciences
- Vol. 10 (6) , 652-656
The relationships between abdominal temperature and some thermoregulatory responses in male broiler chickens
- 1 June 1997
- Published by Asian Australasian Association of Animal Production Societies in Asian-Australasian Journal of Animal Sciences
- Vol. 10 (6) , 652-656
Open AccessThe relationships between abdominal temperature and some thermoregulatory responses in male broiler chickens
- 1 May 1995
- Published by Springer Nature in Abdominal Radiology
- Vol. 20 (3) , 197-200
Portal blood flow in the presence or absence of diffuse liver disease: measurement by phase contrast MR imaging
In patients with diffuse liver disease, the portal flow dynamics change markedly in accordance with disease progression and would provide a useful index of progression of stage. Portal blood flow (PBF) was measured by phase contrast magnetic resonance imaging (MRI) in 21 patients with diffuse liver disease and 20 healthy volunteers. The MRI method was validated by a flow phantom study. The mean PBF could be measured in 6.8 min without breath-holding. Doppler ultrasound measurements of PBF volume were obtained reproducibly in all the healthy volunteers and were shown to correlate with the MRI values (Doppler: 12.5 ±3.2 cm3/s, MRI: 12.0 ± 3.3 cm3/s; mean ± SD). The PBF volume of patients with chronic hepatitis showed no significant difference from that of the healthy volunteers. In patients with liver cirrhosis, the PBF volume ranged from 5.01 to 32.3 cm3/s. A significant increase in PBF volume was caused in one patient by massive intrahepatic shunting and a significant decrease was caused in two patients by massive extrahepatic shunting. The measurement of PBF by phase contrast MRI is clinically useful in predicting intrahepatic or extrahepatic shunting in patients with liver cirrhosis, and may be of value in detecting the progression of stage in diffuse liver diseases.
- 1 May 1995
- Published by Springer Nature in Abdominal Radiology
- Vol. 20 (3) , 197-200
Portal blood flow in the presence or absence of diffuse liver disease: measurement by phase contrast MR imaging
In patients with diffuse liver disease, the portal flow dynamics change markedly in accordance with disease progression and would provide a useful index of progression of stage. Portal blood flow (PBF) was measured by phase contrast magnetic resonance imaging (MRI) in 21 patients with diffuse liver disease and 20 healthy volunteers. The MRI method was validated by a flow phantom study. The mean PBF could be measured in 6.8 min without breath-holding. Doppler ultrasound measurements of PBF volume were obtained reproducibly in all the healthy volunteers and were shown to correlate with the MRI values (Doppler: 12.5 ±3.2 cm3/s, MRI: 12.0 ± 3.3 cm3/s; mean ± SD). The PBF volume of patients with chronic hepatitis showed no significant difference from that of the healthy volunteers. In patients with liver cirrhosis, the PBF volume ranged from 5.01 to 32.3 cm3/s. A significant increase in PBF volume was caused in one patient by massive intrahepatic shunting and a significant decrease was caused in two patients by massive extrahepatic shunting. The measurement of PBF by phase contrast MRI is clinically useful in predicting intrahepatic or extrahepatic shunting in patients with liver cirrhosis, and may be of value in detecting the progression of stage in diffuse liver diseases.